Introducing SanaCurrents Introducing SanaCurrents, a research service for the serious and sophisticated biotech investor. Founder of SanaCurrents, Bill Langbein, finally [...]
Life science investing always has been a roller coaster ride, as well as a minefield, usually with more deep dips [...]
Summary Trading at less than a quarter of valuation of its closest peer that was acquired by Roche in August [...]
This content is password protected. To view it please enter your password below: Password:
22nd Century Group, Inc. (XXII) - Closed a $10 million private placement adding to dilution We will look to add to [...]
Thermal Tennis Inc (OTCCB:TTNS) - CannaSys was originally organized as a Colorado limited liability company in October 2013 and converted [...]
Sciclone Pharmaceuticals (NASDAQ:SCLN)($6.79) - and its partner BTG plc (LSE: BTG), today announced, that the China Food and Drug Administration [...]
Call(s) to Action: XXII, DGLY, NHTC, VRYAF The GeoTeam offers it own rebuttal to XXII’s response to GeoInvesting’s article, “22nd [...]
